152 related articles for article (PubMed ID: 21355086)
1. Telomeric damage in early stage of chronic lymphocytic leukemia correlates with shelterin dysregulation.
Augereau A; T'kint de Roodenbeke C; Simonet T; Bauwens S; Horard B; Callanan M; Leroux D; Jallades L; Salles G; Gilson E; Poncet D
Blood; 2011 Aug; 118(5):1316-22. PubMed ID: 21355086
[TBL] [Abstract][Full Text] [Related]
2. Telomere status in chronic lymphocytic leukemia with TP53 disruption.
Guièze R; Pages M; Véronèse L; Combes P; Lemal R; Gay-Bellile M; Chauvet M; Callanan M; Kwiatkowski F; Pereira B; Vago P; Bay JO; Tournilhac O; Tchirkov A
Oncotarget; 2016 Aug; 7(35):56976-56985. PubMed ID: 27486974
[TBL] [Abstract][Full Text] [Related]
3. In vivo stoichiometry of shelterin components.
Takai KK; Hooper S; Blackwood S; Gandhi R; de Lange T
J Biol Chem; 2010 Jan; 285(2):1457-67. PubMed ID: 19864690
[TBL] [Abstract][Full Text] [Related]
4. Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B-chronic lymphocytic leukemia.
Poncet D; Belleville A; t'kint de Roodenbeke C; Roborel de Climens A; Ben Simon E; Merle-Beral H; Callet-Bauchu E; Salles G; Sabatier L; Delic J; Gilson E
Blood; 2008 Feb; 111(4):2388-91. PubMed ID: 18077792
[TBL] [Abstract][Full Text] [Related]
5. A novel spliced variant of the TIN2 shelterin is present in chronic lymphocytic leukemia.
Ishdorj G; Kost SEF; Beiggi S; Zang Y; Gibson SB; Johnston JB
Leuk Res; 2017 Aug; 59():66-74. PubMed ID: 28575699
[TBL] [Abstract][Full Text] [Related]
6. Telomere dysfunction and fusion during the progression of chronic lymphocytic leukemia: evidence for a telomere crisis.
Lin TT; Letsolo BT; Jones RE; Rowson J; Pratt G; Hewamana S; Fegan C; Pepper C; Baird DM
Blood; 2010 Sep; 116(11):1899-907. PubMed ID: 20538793
[TBL] [Abstract][Full Text] [Related]
7. Germ line mutations in shelterin complex genes are associated with familial chronic lymphocytic leukemia.
Speedy HE; Kinnersley B; Chubb D; Broderick P; Law PJ; Litchfield K; Jayne S; Dyer MJS; Dearden C; Follows GA; Catovsky D; Houlston RS
Blood; 2016 Nov; 128(19):2319-2326. PubMed ID: 27528712
[TBL] [Abstract][Full Text] [Related]
8. Developmental studies of Xenopus shelterin complexes: the message to reset telomere length is already present in the egg.
Vizlin-Hodzic D; Ryme J; Simonsson S; Simonsson T
FASEB J; 2009 Aug; 23(8):2587-94. PubMed ID: 19329760
[TBL] [Abstract][Full Text] [Related]
9. TRF2-tethered TIN2 can mediate telomere protection by TPP1/POT1.
Frescas D; de Lange T
Mol Cell Biol; 2014 Apr; 34(7):1349-62. PubMed ID: 24469404
[TBL] [Abstract][Full Text] [Related]
10. POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia.
Ramsay AJ; Quesada V; Foronda M; Conde L; Martínez-Trillos A; Villamor N; Rodríguez D; Kwarciak A; Garabaya C; Gallardo M; López-Guerra M; López-Guillermo A; Puente XS; Blasco MA; Campo E; López-Otín C
Nat Genet; 2013 May; 45(5):526-30. PubMed ID: 23502782
[TBL] [Abstract][Full Text] [Related]
11. Shelterin: the protein complex that shapes and safeguards human telomeres.
de Lange T
Genes Dev; 2005 Sep; 19(18):2100-10. PubMed ID: 16166375
[TBL] [Abstract][Full Text] [Related]
12. TIN2-tethered TPP1 recruits human telomerase to telomeres in vivo.
Abreu E; Aritonovska E; Reichenbach P; Cristofari G; Culp B; Terns RM; Lingner J; Terns MP
Mol Cell Biol; 2010 Jun; 30(12):2971-82. PubMed ID: 20404094
[TBL] [Abstract][Full Text] [Related]
13. Dysfunctional telomeres activate an ATM-ATR-dependent DNA damage response to suppress tumorigenesis.
Guo X; Deng Y; Lin Y; Cosme-Blanco W; Chan S; He H; Yuan G; Brown EJ; Chang S
EMBO J; 2007 Nov; 26(22):4709-19. PubMed ID: 17948054
[TBL] [Abstract][Full Text] [Related]
14. TPP1 is a homologue of ciliate TEBP-beta and interacts with POT1 to recruit telomerase.
Xin H; Liu D; Wan M; Safari A; Kim H; Sun W; O'Connor MS; Songyang Z
Nature; 2007 Feb; 445(7127):559-62. PubMed ID: 17237767
[TBL] [Abstract][Full Text] [Related]
15. Telomere length, TERT and shelterin complex proteins in hepatocellular carcinomas expressing "stemness"-related markers.
Kim H; Yoo JE; Cho JY; Oh BK; Yoon YS; Han HS; Lee HS; Jang JJ; Jeong SH; Kim JW; Park YN
J Hepatol; 2013 Oct; 59(4):746-52. PubMed ID: 23685049
[TBL] [Abstract][Full Text] [Related]
16. TRF1 as a major contributor for telomeres' shortening in the context of obesity.
Grun LK; Teixeira NDR; Mengden LV; de Bastiani MA; Parisi MM; Bortolin R; Lavandoski P; Pierdoná V; Alves LB; Moreira JCF; Mottin CC; Jones MH; Klamt F; Padoin AV; Guma FCR; Barbé-Tuana FM
Free Radic Biol Med; 2018 Dec; 129():286-295. PubMed ID: 30268887
[TBL] [Abstract][Full Text] [Related]
17. Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy.
Gramatges MM; Bertuch AA
Transl Res; 2013 Dec; 162(6):353-63. PubMed ID: 23732052
[TBL] [Abstract][Full Text] [Related]
18. A siRNA-based screen for genes involved in chromosome end protection.
Lackner DH; Durocher D; Karlseder J
PLoS One; 2011; 6(6):e21407. PubMed ID: 21760879
[TBL] [Abstract][Full Text] [Related]
19. Telomere dysfunction-induced foci arise with the onset of telomeric deletions and complex chromosomal aberrations in resistant chronic lymphocytic leukemia cells.
Brugat T; Nguyen-Khac F; Grelier A; Merle-Béral H; Delic J
Blood; 2010 Jul; 116(2):239-49. PubMed ID: 20424183
[TBL] [Abstract][Full Text] [Related]
20. Association between telomere length and V(H) gene mutation status in chronic lymphocytic leukaemia: clinical and biological implications.
Hultdin M; Rosenquist R; Thunberg U; Tobin G; Norrback KF; Johnson A; Sundström C; Roos G
Br J Cancer; 2003 Feb; 88(4):593-8. PubMed ID: 12592375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
